Advancing the Patient Experience in COPD Registry (APEX COPD)

Study identification

• PURI:
  https://redirect.ema.europa.eu/resource/50777
• EU PAS number:
  EUPAS29401
• Study ID:
  50777
• Official title and acronym:
  Advancing the Patient Experience in COPD Registry (APEX COPD)
• DARWIN EU® study:
  No
• Study countries:
  United States
• Study description:
  The initiative aims to improve primary care for COPD patients. It will bring together electronic medical records with patient reported information and observations, and present this to clinicians in a structured and clinically relevant format at the point of care. This will be achieved using modern technology, including FHIR, electronic patient surveys, and standardized data collection, and will be guided by a network of COPD physicians in primary and secondary care. Impact will be maximised through Research publications regarding treatment effectiveness and associated risk in mild to moderate COPD, reason for therapy switch/escalation and hidden undiagnosed and untreated COPD patients in primary care. A strong network of COPD primary care physicians in the US is driving the initiative and will ensure impact on clinical practice through academic organisations and research outputs.
• Study status:
  Planned

Research institutions and networks

Institutions

Optimum Patient Care Australia

Australia

Networks

DARTNet Institute

Study timelines

Date when funding contract was signed

Planned: 27/12/2018

Actual: 27/12/2018

Study start date

Planned: 01/07/2019

Data analysis start date

Planned: 02/09/2019

Date of final study report

Planned: 29/12/2023

Sources of funding

Other

Pharmaceutical company and other private sector 

More details on funding

Boehringer Ingelheim, Inc., Optimum Patient Care Ltd.

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable